<DOC>
	<DOCNO>NCT02129907</DOCNO>
	<brief_summary>In total 50 subject iron deficiency anemia treat intravenous iron plan inclusion trial . After sign informed consent blood sample obtain participant iron treatment . The investigator measure thrombin generation plasma assess calibrate automated thrombogram ( CAT ) . patient go face face interview ask answer structure questionnaire include information demographic , clinical data ( fever , allergy , etc . ) comorbidities Two week complete intravenous iron administration additional blood sample take : thrombin generation measure</brief_summary>
	<brief_title>The Purpose Study Examine Whether Iron Deficiency Anemia Associated With Increased Production Thrombin Whether Correction Anemia Providing Iron Intravenously Causes Significant Reduction Production Thrombin .</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>age &gt; 18 year Iron deficiency anemia response oral iron treatment plan receive iron supplement intravenously . Signing informed consent exclusion criterion : chronic inflammatory disease renal failure Malignancy Infectious disease Other reason anemia except iron deficiency anemia . Pregnant woman Use anti aggregate agent anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Anemias</keyword>
	<keyword>Iron-Deficiency</keyword>
	<keyword>thrombin</keyword>
</DOC>